PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.

Income Statement Profarma Distribuidora de Produtos Farmacêuticos S.A.

Stocks

PFRM3

BRPFRMACNOR1

Pharmaceuticals

Market Closed - Sao Paulo Other stock markets 21:04:00 08/07/2026 BST			5-day change	1st Jan Change
6.670 ^BRL	-1.91%		-0.45%	-26.94%

05-07	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-15	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025	CI

26d866bf28ce2010c0f194c.9jNVbk9Iv9t_Q20NuPPXvj8gooDTSXMoRWM41_dq5qA.22ljIBUg0poZOylI-6eE83BW7e6VI0saMjlnmpk9tsugVGJaIALo7E0KJA

Published financial data: PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	6.41B	7.82B	8.66B	10.15B	11.45B
Total Revenues	6.41B	7.82B	8.66B	10.15B	11.45B
Cost of Goods Sold, Total	5.51B	6.67B	7.37B	8.63B	9.7B
Gross Profit	908M	1.15B	1.29B	1.52B	1.75B
Selling General & Admin Expenses, Total	668M	779M	1.05B	1.22B	1.37B
Provision for Bad Debts	-1.69M	835K	-	-	-
Depreciation & Amortization - (IS)	114M	127M	-	-	-
Other Operating Expenses	-9.64M	-15.1M	-15.5M	-1.79M	31.49M
Other Operating Expenses, Total	771M	892M	1.03B	1.22B	1.4B
Operating Income	136M	254M	261M	300M	350M
Interest Expense, Total	-76.16M	-149M	-162M	-149M	-201M
Interest And Investment Income	4.9M	8.68M	10.95M	8.3M	14.53M
Net Interest Expenses	-71.26M	-141M	-151M	-141M	-187M
Income (Loss) On Equity Invest.	5.98M	-7K	11K	35K	-182K
Other Non Operating Income (Expenses)	-10.71M	-23.46M	-28.59M	-30.74M	-45.85M
EBT, Excl. Unusual Items	60.26M	89.82M	81.59M	128M	117M
Impairment of Goodwill	-11.52M	-10.85M	-	-	-
EBT, Incl. Unusual Items	48.75M	78.97M	81.59M	128M	117M
Income Tax Expense	-30.37M	-6.07M	3.74M	5.05M	-8.55M
Earnings From Continuing Operations	79.11M	85.04M	77.86M	123M	126M
Net Income to Company	79.11M	85.04M	77.86M	123M	126M
Minority Interest	-921K	-4.17M	-7.46M	-8.23M	-7.12M
Net Income - (IS)	78.19M	80.87M	70.4M	115M	119M
Net Income to Common Incl Extra Items	78.19M	80.87M	70.4M	115M	119M
Net Income to Common Excl. Extra Items	78.19M	80.87M	70.4M	115M	119M
Per Share Items
Net EPS - Basic	0.64	0.66	0.57	0.93	0.97
Basic EPS - Continuing Operations	0.64	0.66	0.57	0.93	0.97
Basic Weighted Average Shares Outstanding	123M	123M	123M	123M	123M
Net EPS - Diluted	0.64	0.66	0.57	0.93	0.97
Diluted EPS - Continuing Operations	0.64	0.66	0.57	0.93	0.97
Diluted Weighted Average Shares Outstanding	123M	123M	123M	123M	123M
Normalized Basic EPS	0.3	0.42	0.36	0.58	0.54
Normalized Diluted EPS	0.3	0.42	0.36	0.58	0.54
Dividend Per Share	0.27	0.17	0.39	0.58	-
Payout Ratio	37.24	-	44.36	47.63	64.48
Supplemental Items
EBITDA	163M	284M	296M	342M	404M
EBITA	136M	254M	261M	300M	350M
EBIT	136M	254M	261M	300M	350M
EBITDAR	168M	293M	305M	355M	418M
Effective Tax Rate - (Ratio)	-62.3	-7.69	4.58	3.95	-7.28
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	798K	3.95M	9.84M	13.56M	13.13M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-31.16M	-10.02M	-6.1M	-8.51M	-21.68M
Normalized Net Income	36.74M	51.97M	43.53M	71.68M	66.3M
Interest on Long-Term Debt	24.35M	34.54M	38.64M	45.31M	64.6M
Supplemental Operating Expense Items
Selling and Marketing Expenses	528M	610M	804M	922M	1.02B
General and Administrative Expenses	140M	169M	243M	303M	345M
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	4.83M	9M	8.91M	12.77M	13.11M
Imputed Operating Lease Interest Expense	3.19M	10.9M	10.64M	12.77M	15.93M
Imputed Operating Lease Depreciation	1.64M	-1.9M	-1.74M	1.33K	-2.82M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	189M	183M	194M	230M	235M
Total Cash And Short Term Investments	189M	183M	194M	230M	235M
Accounts Receivable, Total	831M	1.04B	1.19B	1.39B	1.56B
Other Receivables	448M	498M	601M	536M	568M
Total Receivables	1.28B	1.54B	1.79B	1.93B	2.12B
Inventory	1.08B	1.24B	1.53B	1.82B	2.1B
Prepaid Expenses	8.72M	8.67M	10.43M	12.26M	8.48M
Other Current Assets, Total	20.55M	11.1M	19.66M	28.25M	31.71M
Total Current Assets	2.58B	2.98B	3.54B	4.02B	4.49B
Gross Property Plant And Equipment	923M	1.03B	1.18B	1.47B	994M
Accumulated Depreciation	-404M	-519M	-643M	-794M	-170M
Net Property Plant And Equipment	519M	507M	536M	674M	824M
Long-term Investments	-	1.99M	2M	2.04M	1.86M
Goodwill	495M	488M	483M	486M	480M
Other Intangibles, Total	129M	131M	135M	143M	156M
Deferred Tax Assets Long-Term	164M	177M	184M	234M	227M
Other Long-Term Assets, Total	144M	78.96M	58.96M	56.48M	51.19M
Total Assets	4.03B	4.36B	4.94B	5.62B	6.23B
Liabilities
Accounts Payable, Total	1.33B	1.49B	1.82B	2.2B	2.62B
Accrued Expenses, Total	120M	148M	174M	91.68M	248M
Current Portion of Long-Term Debt	118M	131M	206M	249M	311M
Current Portion of Leases	89.18M	90.9M	92.51M	111M	116M
Current Income Taxes Payable	154K	178K	2.29M	130M	2.7M
Unearned Revenue Current, Total	-	21.51M	49.37M	110M	54.35M
Other Current Liabilities	57.22M	79.48M	102M	103M	131M
Total Current Liabilities	1.72B	1.96B	2.45B	2.99B	3.48B
Long-Term Debt	441M	533M	574M	551M	564M
Long-Term Leases	299M	270M	271M	336M	411M
Deferred Tax Liability Non Current	38.06M	41.42M	40.22M	82.12M	54.48M
Other Non Current Liabilities	62.02M	54.33M	67.13M	71.66M	84.6M
Total Liabilities	2.56B	2.85B	3.4B	4.03B	4.6B
Common Stock, Total	1.04B	1.04B	1.04B	919M	1.06B
Retained Earnings	97.35M	157M	180M	224M	124M
Treasury Stock	-16.37M	-16.37M	-16.37M	-16.37M	-16.37M
Comprehensive Income and Other	-38.58M	6.74M	40.98M	177M	179M
Total Common Equity	1.09B	1.19B	1.25B	1.3B	1.35B
Minority Interest	390M	320M	291M	283M	290M
Total Equity	1.48B	1.51B	1.54B	1.59B	1.64B
Total Liabilities And Equity	4.03B	4.36B	4.94B	5.62B	6.23B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	123M	123M	123M	123M	123M
ECS Total Common Shares Outstanding	123M	123M	123M	123M	123M
Book Value / Share	8.86	9.71	10.18	10.63	10.98
Tangible Book Value	462M	572M	630M	674M	710M
Tangible Book Value Per Share	3.77	4.66	5.14	5.5	5.79
Total Debt	947M	1.02B	1.14B	1.25B	1.4B
Net Debt	758M	841M	950M	1.02B	1.17B
Debt Equivalent Oper. Leases	38.65M	71.98M	71.26M	102M	105M
Minority Interest, Total (Incl. Fin. Div)	390M	320M	291M	283M	290M
Equity Method Investments, Total	-	1.99M	2M	2.04M	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	-	-	81.4M	39.11M	37.86M
Inventories - Finished Goods, Total	1.09B	1.24B	1.45B	1.79B	2.07B
Inventories - Others	-	-	-	-	-
Machinery, Total	194M	216M	237M	281M	146M
Full Time Employees	7.08K	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	26.98M	28.52M	38.37M	39.38M	50.44M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	78.19M	80.87M	70.4M	115M	119M
Depreciation & Amortization - CF	112M	124M	133M	153M	180M
Amortization of Goodwill and Intangible Assets - (CF)	23K	11K	-	-	-
Depreciation & Amortization, Total	112M	124M	133M	153M	180M
Amortization of Deferred Charges, Total - (CF)	2.15M	3.1M	4.62M	6.45M	9.45M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-28.85M	-	-	-1.36M
Asset Writedown & Restructuring Costs	12.39M	14.21M	12.16M	10.96M	15.09M
(Income) Loss On Equity Investments - (CF)	-5.98M	7K	-11K	-35K	182K
Provision and Write-off of Bad Debts	12.26M	10.83M	13.13M	13.32M	15.88M
Other Operating Activities, Total	44M	165M	166M	173M	215M
Change In Accounts Receivable	-120M	-222M	-215M	-253M	-169M
Change In Inventories	-151M	-153M	-288M	-301M	-296M
Change In Accounts Payable	189M	175M	417M	488M	387M
Change In Income Taxes	-39.49M	-21.81M	10.4M	-5.88M	10.84M
Change in Other Net Operating Assets	-25.6M	-20.84M	-62.94M	98.54M	-26.6M
Cash from Operations	108M	126M	261M	497M	460M
Capital Expenditure	-68.53M	-59.95M	-67.53M	-103M	-147M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-13.55M	-10.51M	-14.01M	-28.05M	-29.41M
Investment in Marketable and Equity Securities, Total	-4.33M	48.72M	-15.04M	-6.26M	-
Cash from Investing	-86.41M	-21.74M	-96.58M	-137M	-176M
Long-Term Debt Issued, Total	552M	891M	1.08B	469M	1.02B
Total Debt Issued	552M	891M	1.08B	469M	1.02B
Long-Term Debt Repaid, Total	-692M	-899M	-1.05B	-589M	-1.04B
Total Debt Repaid	-692M	-899M	-1.05B	-589M	-1.04B
Issuance of Common Stock	-	-	-	-	-
Common Dividends Paid	-29.12M	-	-31.23M	-54.58M	-76.67M
Common & Preferred Stock Dividends Paid	-29.12M	-	-31.23M	-54.58M	-76.67M
Other Financing Activities, Total	-35.72M	-102M	-157M	-150M	-187M
Cash from Financing	-204M	-110M	-154M	-324M	-278M
Net Change in Cash	-183M	-5.26M	10.49M	35.81M	5.57M
Supplemental Items
Cash Interest Paid	35.72M	102M	157M	150M	187M
Cash Income Tax Paid (Refund)	586K	5.06M	8.93M	13.22M	-12.9M
Levered Free Cash Flow	-10.87M	-57.05M	-16.86M	160M	65.89M
Unlevered Free Cash Flow	36.73M	36.2M	84.33M	253M	192M
Change In Net Working Capital	80.72M	179M	135M	-37.14M	40.47M
Net Debt Issued / Repaid	-140M	-7.41M	34.86M	-120M	-13.91M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.19	3.78	3.51	3.55	3.69
Return on Total Capital	3.58	6.4	6.26	6.79	7.46
Return On Equity %	5.44	5.69	5.11	7.86	7.82
Return on Common Equity	7.33	7.1	5.77	8.98	8.98
Margin Analysis
Gross Profit Margin %	14.15	14.66	14.92	15	15.29
SG&A Margin	10.42	9.96	12.08	12.06	11.95
EBITDA Margin %	2.54	3.64	3.41	3.37	3.53
EBITA Margin %	2.12	3.25	3.01	2.95	3.06
EBIT Margin %	2.12	3.25	3.01	2.95	3.06
Income From Continuing Operations Margin %	1.23	1.09	0.9	1.21	1.1
Net Income Margin %	1.22	1.03	0.81	1.13	1.04
Net Avail. For Common Margin %	1.22	1.03	0.81	1.13	1.04
Normalized Net Income Margin	0.57	0.66	0.5	0.71	0.58
Levered Free Cash Flow Margin	-0.17	-0.73	-0.19	1.57	0.58
Unlevered Free Cash Flow Margin	0.57	0.46	0.97	2.49	1.67
Asset Turnover
Asset Turnover	1.65	1.86	1.86	1.92	1.93
Fixed Assets Turnover	14.07	15.24	16.62	16.79	15.28
Receivables Turnover (Average Receivables)	8.05	8.34	7.77	7.87	7.76
Inventory Turnover (Average Inventory)	5.54	5.75	5.33	5.16	4.95
Short Term Liquidity
Current Ratio	1.5	1.52	1.45	1.34	1.29
Quick Ratio	0.86	0.88	0.81	0.72	0.68
Operating Cash Flow to Current Liabilities	0.06	0.06	0.11	0.17	0.13
Days Sales Outstanding (Average Receivables)	45.34	43.78	47	46.52	47.01
Days Outstanding Inventory (Average Inventory)	65.91	63.48	68.43	70.99	73.67
Average Days Payable Outstanding	79.55	74.16	78.75	82.35	88.13
Cash Conversion Cycle (Average Days)	31.71	33.1	36.68	35.15	32.55
Long Term Solvency
Total Debt/Equity	64.16	67.8	74.31	78.62	85.71
Total Debt / Total Capital	39.08	40.41	42.63	44.01	46.15
LT Debt/Equity	50.14	53.11	54.9	55.96	59.59
Long-Term Debt / Total Capital	30.55	31.65	31.49	31.33	32.09
Total Liabilities / Total Assets	63.4	65.39	68.83	71.76	73.76
EBIT / Interest Expense	1.79	1.7	1.61	2.01	1.74
EBITDA / Interest Expense	3.26	2.53	2.43	3.03	2.63
(EBITDA - Capex) / Interest Expense	2.36	2.13	2.02	2.34	1.91
Total Debt / EBITDA	3.81	2.71	2.9	2.75	2.64
Net Debt / EBITDA	3.05	2.22	2.41	2.25	2.2
Total Debt / (EBITDA - Capex)	5.26	3.22	3.5	3.56	3.66
Net Debt / (EBITDA - Capex)	4.21	2.64	2.91	2.91	3.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17	21.88	10.82	17.22	12.77
Gross Profit, 1 Yr. Growth %	18.86	26.22	12.78	17.87	14.95
EBITDA, 1 Yr. Growth %	8.54	74.65	8.16	15.73	18.21
EBITA, 1 Yr. Growth %	6.23	86.25	7.47	14.76	16.85
EBIT, 1 Yr. Growth %	6.22	86.27	7.48	14.76	16.85
Earnings From Cont. Operations, 1 Yr. Growth %	28.02	7.49	-8.45	57.74	2.61
Net Income, 1 Yr. Growth %	49.41	3.43	-12.95	62.76	3.77
Normalized Net Income, 1 Yr. Growth %	97.64	41.45	-3.66	64.65	-7.51
Diluted EPS Before Extra, 1 Yr. Growth %	49.41	3.43	-12.98	62.72	3.82
Accounts Receivable, 1 Yr. Growth %	9.12	25.51	13.76	17.4	11.64
Inventory, 1 Yr. Growth %	20	13.92	23.63	19.17	15.09
Net Property, Plant and Equip., 1 Yr. Growth %	32.19	-2.32	5.64	25.88	22.27
Total Assets, 1 Yr. Growth %	7.23	8.23	13.13	13.74	11
Tangible Book Value, 1 Yr. Growth %	9.46	23.78	10.31	6.87	5.33
Common Equity, 1 Yr. Growth %	3.8	9.66	4.81	4.39	3.27
Cash From Operations, 1 Yr. Growth %	173.42	17.43	106.53	90.53	-7.52
Capital Expenditures, 1 Yr. Growth %	90.13	-12.52	12.64	51.83	43.12
Levered Free Cash Flow, 1 Yr. Growth %	-57.07	424.82	-73.59	-1.05K	-61.94
Unlevered Free Cash Flow, 1 Yr. Growth %	120.04	-1.43	186.62	200.24	-28.09
Dividend Per Share, 1 Yr. Growth %	-	-35.94	122.58	49.05	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.57	19.41	16.22	13.98	14.98
Gross Profit, 2 Yr. CAGR %	10.91	22.48	19.31	15.3	16.4
EBITDA, 2 Yr. CAGR %	13.4	37.68	34.79	11.88	16.96
EBITA, 2 Yr. CAGR %	13.66	40.66	38.43	11.06	15.8
EBIT, 2 Yr. CAGR %	13.67	40.66	38.44	11.06	15.8
Earnings From Cont. Operations, 2 Yr. CAGR %	157	17.31	-0.8	20.17	27.22
Net Income, 2 Yr. CAGR %	155.5	24.31	-5.12	19.03	29.96
Normalized Net Income, 2 Yr. CAGR %	255.26	67.2	8.85	25.94	23.41
Diluted EPS Before Extra, 2 Yr. CAGR %	155.5	24.31	-5.13	19	29.98
Accounts Receivable, 2 Yr. CAGR %	22.57	17.03	19.49	15.57	14.49
Inventory, 2 Yr. CAGR %	9.92	16.92	18.68	21.38	17.11
Net Property, Plant and Equip., 2 Yr. CAGR %	29.22	13.64	1.58	15.31	24.06
Total Assets, 2 Yr. CAGR %	12.55	7.73	10.65	13.43	12.36
Tangible Book Value, 2 Yr. CAGR %	10.84	16.4	16.85	8.58	6.1
Common Equity, 2 Yr. CAGR %	3.97	6.69	7.21	4.6	3.83
Cash From Operations, 2 Yr. CAGR %	-8.18	79.18	55.73	98.37	32.74
Capital Expenditures, 2 Yr. CAGR %	78.81	28.97	-0.73	30.77	47.41
Levered Free Cash Flow, 2 Yr. CAGR %	-36.1	50.1	24.54	58.23	97.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	7.84	47.27	51.52	193.35	50.74
Dividend Per Share, 2 Yr. CAGR %	-	-	19.41	82.14	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.51	17.64	16.48	16.55	13.57
Gross Profit, 3 Yr. CAGR %	10.05	15.79	19.16	18.83	15.18
EBITDA, 3 Yr. CAGR %	29.37	30.96	25.4	28.11	13.95
EBITA, 3 Yr. CAGR %	35.56	34	26.73	30.04	12.95
EBIT, 3 Yr. CAGR %	35.58	34.01	26.74	30.04	12.95
Earnings From Cont. Operations, 3 Yr. CAGR %	101.06	92.2	8.01	15.79	14.01
Net Income, 3 Yr. CAGR %	100.27	89.01	10.39	13.58	13.71
Normalized Net Income, 3 Yr. CAGR %	27.62	161.35	32.8	24.95	13.63
Diluted EPS Before Extra, 3 Yr. CAGR %	97.25	89.01	10.38	13.56	13.71
Accounts Receivable, 3 Yr. CAGR %	15.1	23.54	15.93	18.79	14.24
Inventory, 3 Yr. CAGR %	10.9	11.24	19.12	18.84	19.25
Net Property, Plant and Equip., 3 Yr. CAGR %	59.09	17.71	10.91	9.11	17.59
Total Assets, 3 Yr. CAGR %	11.75	11.1	9.5	11.67	12.62
Tangible Book Value, 3 Yr. CAGR %	9.67	14.99	14.33	13.42	7.48
Common Equity, 3 Yr. CAGR %	2.07	5.84	6.06	6.26	4.16
Cash From Operations, 3 Yr. CAGR %	24.43	-0.34	87.87	66.56	53.82
Capital Expenditures, 3 Yr. CAGR %	78.34	40.9	23.28	14.37	34.76
Levered Free Cash Flow, 3 Yr. CAGR %	-8.38	28.92	-12.68	144.98	1.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	10.09	4.66	71.59	90.32	86.75
Dividend Per Share, 3 Yr. CAGR %	-	-	-	28.57	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.44	13.77	15.19	16.16	15.87
Gross Profit, 5 Yr. CAGR %	7.74	10.32	13.67	15.59	18.05
EBITDA, 5 Yr. CAGR %	9.96	64.86	31.52	22.01	21.96
EBITA, 5 Yr. CAGR %	10.76	99.01	36.7	23.22	22.24
EBIT, 5 Yr. CAGR %	10.76	99.01	36.71	23.23	22.24
Earnings From Cont. Operations, 5 Yr. CAGR %	10.07	-5.48	51.57	59.28	15.32
Net Income, 5 Yr. CAGR %	9.81	-6.42	48.54	57.09	17.84
Normalized Net Income, 5 Yr. CAGR %	2.32	-11.55	19.75	89.79	28.96
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.95	-15.82	47.19	57.07	17.84
Accounts Receivable, 5 Yr. CAGR %	9.54	17.63	16.84	20.29	15.35
Inventory, 5 Yr. CAGR %	10.8	14.41	13.95	15.19	18.31
Net Property, Plant and Equip., 5 Yr. CAGR %	35.88	30.1	32.96	16.75	15.99
Total Assets, 5 Yr. CAGR %	8.26	10.75	11.31	12.02	10.64
Tangible Book Value, 5 Yr. CAGR %	68.61	54.92	12.49	12.38	10.96
Common Equity, 5 Yr. CAGR %	7.43	9.81	4.1	5.34	5.16
Cash From Operations, 5 Yr. CAGR %	0.05	19.5	36.11	31.25	63.5
Capital Expenditures, 5 Yr. CAGR %	19.54	4.66	41.08	36.76	32.42
Levered Free Cash Flow, 5 Yr. CAGR %	-34.72	-16.65	3.59	43.11	21.08
Unlevered Free Cash Flow, 5 Yr. CAGR %	38.94	-1.84	25.1	51.63	62.93